Citations (32)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (8)
Ka Wai Kam, Li Jia Chen, Noel Wat & Alvin L. Young. (2017) Topical Olopatadine in the Treatment of Allergic Conjunctivitis: A Systematic Review and Meta-analysis. Ocular Immunology and Inflammation 25:5, pages 668-682.
Read now
Read now
Rengin Aslıhan Kurt, Ömür Ucakhan-Gündüz & Kaan Gündüz. (2010) Olopatadine 0.1% and 0.2% ophthalmic solution for the management of ocular allergy. Expert Review of Ophthalmology 5:3, pages 287-296.
Read now
Read now
Andrea Leonardi & Luigi Quintieri. (2010) Olopatadine: a drug for allergic conjunctivitis targeting the mast cell. Expert Opinion on Pharmacotherapy 11:6, pages 969-981.
Read now
Read now
Andrea Leonardi & Bob Lanier. (2008) Urban eye allergy syndrome: a new clinical entity?. Current Medical Research and Opinion 24:8, pages 2295-2302.
Read now
Read now
F. S. Mah, T. O’Brien, T. Kim & G. Torkildsen. (2008) Evaluation of the effects of olopatadine ophthalmic solution, 0.2% on the ocular surface of patients with allergic conjunctivitis and dry eye. Current Medical Research and Opinion 24:2, pages 441-447.
Read now
Read now
Andrea Leonardi. (2007) New drug treatments for ocular allergies. Expert Review of Ophthalmology 2:3, pages 397-408.
Read now
Read now
William E Berger. (2007) Once-daily olopatadine ophthalmic solution 0.2% in the treatment of allergic conjunctivitis and rhinoconjunctivitis. Expert Review of Pharmacoeconomics & Outcomes Research 7:3, pages 221-226.
Read now
Read now
Huei-Jen Kao, Yu-Li Lo, Wen-Jong Vong, Yiu-Jiuan Lin & Hong-Ru Lin. (2006) Treating allergic conjunctivitis using in situ polyelectrolyte gelling systems. Journal of Biomaterials Science, Polymer Edition 17:10, pages 1191-1205.
Read now
Read now
Articles from other publishers (24)
Sa-Haeng Kang, Dong-Gu Kim, Dong-Keun Kim, Hyuck-Se Kwon, Na-Young Lee, Hyun-Jeong Oh, Soon-Il Yun & Jong-Sik Jin. (2023) Effects of Thymus quinquecostatus Celakovski on Allergic Responses in OVA-Induced Allergic Rhinitis Mice. Applied Sciences 13:22, pages 12449.
Crossref
Crossref
S Mohan, Santosh Kumar, G Pawan Kumar, Anjali Maheswari, Agrima Bhatia & Anand Sagar. (2023) Assessment of the efficacy of olopatadine 0.1% in the treatment of vernal keratoconjunctivitis in terms of clinical improvement based on total ocular symptom score and ocular surface disease index. Indian Journal of Ophthalmology 71:5, pages 1822-1827.
Crossref
Crossref
Cheng Wang, Yajing Hou, Shuai Ge, Jiayu Lu, Xiangjun Wang, Yuexin Lv, Nan Wang & Huaizhen He. (2022) Synthetic imperatorin derivatives alleviate allergic reactions via mast cells. Biomedicine & Pharmacotherapy 150, pages 112982.
Crossref
Crossref
Maria Malvina Tsamouri, Blythe P. Durbin-Johnson, William T. N. Culp, Carrie A. Palm, Mamta Parikh, Michael S. Kent & Paramita M. Ghosh. (2022) Untargeted Metabolomics Identify a Panel of Urinary Biomarkers for the Diagnosis of Urothelial Carcinoma of the Bladder, as Compared to Urolithiasis with or without Urinary Tract Infection in Dogs. Metabolites 12:3, pages 200.
Crossref
Crossref
Bahareh Hafezi, Lily Chan, Jason P. Knapp, Negar Karimi, Kimia Alizadeh, Yeganeh Mehrani, Byram W. Bridle & Khalil Karimi. (2021) Cytokine Storm Syndrome in SARS-CoV-2 Infections: A Functional Role of Mast Cells. Cells 10:7, pages 1761.
Crossref
Crossref
M. A. Kovalevskaya & L. A. Filina. (2020) Clinical forms of allergic eye manifestations: prospects of therapy. Russian Ophthalmological Journal 13:1, pages 94-101.
Crossref
Crossref
Andrea Leonardi, Diana Silva, Daniel Perez Formigo, Banu Bozkurt, Vibha Sharma, Pia Allegri, Carmen Rondon, Virginia Calder, Dermot Ryan, Marek L. Kowalski, Luis Delgado, Serge Doan & Jean L. Fauquert. (2019) Management of ocular allergy. Allergy 74:9, pages 1611-1630.
Crossref
Crossref
Ketan M. Ranch, Furqan A. Maulvi, Mausam J. Naik, Akshay R. Koli, Rajesh K. Parikh & Dinesh O. Shah. (2019) Optimization of a novel in situ gel for sustained ocular drug delivery using Box-Behnken design: In vitro, ex vivo, in vivo and human studies. International Journal of Pharmaceutics 554, pages 264-275.
Crossref
Crossref
D. Elieh Ali Komi, T. Rambasek & L. Bielory. (2018) Clinical implications of mast cell involvement in allergic conjunctivitis. Allergy 73:3, pages 528-539.
Crossref
Crossref
Jelena Maksić, Ana Stajić, Miroslav Knežević, Bojana Dačić Krnjaja, Biljana Jančić–Stojanović & Mirjana Medenica. (2017) Determination of olopatadine in human tears by hydrophilic interaction liquid chromatography–MS/MS method. Bioanalysis 9:24, pages 1943-1954.
Crossref
Crossref
Marta Łaszcz, Kinga Trzcińska, Anna Witkowska, Agnieszka Ciesielska, Katarzyna Badowska-Rosłonek & Krzysztof Kuziak. (2016) Structural and Physicochemical Studies of Olopatadine Hydrochloride Conformational Polymorphs. Journal of Pharmaceutical Sciences 105:8, pages 2419-2426.
Crossref
Crossref
Ruben Vardanyan & Victor Hruby. 2016. Synthesis of Best-Seller Drugs. Synthesis of Best-Seller Drugs
247
263
.
Soo-Wan Choi, Ju-Hee Ryu, Ji-Sun Park, Myung-Jae Lee, Sung-Vin Yim & Kyung-Tae Lee. (2015) Development and validation for the determination of olopatadine in human plasma by liquid chromatography–tandem mass spectrometry: application to a bioequivalence study of Ilhwa Allotadine tablet (olopatadine HCl 5 mg). Journal of Pharmaceutical Investigation 45:3, pages 285-292.
Crossref
Crossref
L. Munjas Jurkic, M. Buratovic, I. Valentic & D. Stanfel. (2014) UHPLC Study on the Degradation Profiles of Olopatadine Hydrochloride in Eye Drops Subjected to Heat and Filtration Methods of Sterilisation. Chromatographia 77:15-16, pages 1067-1080.
Crossref
Crossref
Hyo Won Jung, Jin Ki Jung & Yong-Ki Park. (2013) Comparison of the efficacy of KOB03, ketotifen, and montelukast in an experimental mouse model of allergic rhinitis. International Immunopharmacology 16:2, pages 254-260.
Crossref
Crossref
N E Leppenen & A N Pampura. (2012) Allergic conjunctivitis in children: from pathogenesis to therapy. Russian Journal of Allergy 9:1, pages 73-78.
Crossref
Crossref
Jin-Ki Jung & Yong-Ki Park. (2012) Effects of Saposhnikoviae Radix on allergic responses in OVA-induced Allergic rhinitis mice. The Korea Journal of Herbology 27:5, pages 85-91.
Crossref
Crossref
Seok-Yong Kang, Seung-Ug Hong & Yong-Ki Park. (2012) Effects of KOB, a polyherbal medicine for allergic rhinitis and its main herb, Astragali Radix on allergic responses in OVA-induced Allergic rhinitis mice. The Korea Journal of Herbology 27:4, pages 1-7.
Crossref
Crossref
Shuang Liu, Agung Endro Nugroho, Masachika Shudou & Kazutaka Maeyama. (2011) Regulation of mucosal mast cell activation by short interfering RNAs targeting syntaxin4. Immunology & Cell Biology 90:3, pages 337-345.
Crossref
Crossref
Oksana Mikhaylovna Kurbacheva & K S Pavlova. (2011) Allergicheskiy kon\"yunktivit:sovremennyy vzglyad na aktual'nuyuproblemu. Russian Journal of Allergy 8:1, pages 82-87.
Crossref
Crossref
Daisuke Kurihara, Nobuyuki Fukuishi, Kazue Kadota, Hirofumi Hamano, Hayato Teruya, Nobuaki Matsui & Masaaki Akagi. (2011) Mast Cells Modulate Interleukin-4 Production Independently of Interferon-gamma Generation by Invariant Natural Killer T Cells through the Suppression of Notch Signaling. JOURNAL OF HEALTH SCIENCE Journal of Health Science 57:2, pages 197-203.
Crossref
Crossref
Alessandro Lambiase, Alessandra Micera & Stefano Bonini. (2009) Multiple action agents and the eye: do they really stabilize mast cells?. Current Opinion in Allergy & Clinical Immunology 9:5, pages 454-465.
Crossref
Crossref
JOHN M. YANNI & NEAL P. BARNEY. 2008. Ocular Therapeutics. Ocular Therapeutics
239
274
.
Steven J. LichtensteinTerry A. PasquineMichael R. EdwardsDavid T. WellsRobert D. GrossStella M. Robertson. (2007) Safety and Tolerability of Olopatadine 0.2% in Children and Adolescents. Journal of Ocular Pharmacology and Therapeutics 23:4, pages 366-371.
Crossref
Crossref